13Oct

Improved Nucleic Acid Isolation

The QuickGene series of instruments and kits from Alpha Laboratories provides a novel, innovate method for DNA and RNA extraction from a vast number of sample types, all without the need for strong centrifugation steps, or centrifugation at all.  Improve workflow and remove the danger of unbalanced centrifuges and the hassle of overbooked machines.

 

The range of QuickGene kits enables extraction of DNA and RNA from samples up to 2mL in size and from a plethora of different sources, including viruses, bacteria, cultured cells, whole blood, animal and plant tissue.

 

As with other solid-phase extraction techniques QuickGene passes samples through a thin hydrophobic membrane allowing hydrophilic molecules to pass through whilst keeping hydrophobic molecules, such as nucleic acids, retained in the membrane for elution and collection.  QuickGene porous membranes are just 100μm thick, merely 10% of the size of traditional 1000μm thick glass fibre membranes.

 

Using compressed air is a more gentle process, protecting nucleic acids which in turn provides longer, more complete strands, all whilst retaining impeccable sample purity and yield, giving more confidence in results.

 

The range encompasses two instruments for semi-automation, two instruments for full automation and an adapter to allow seamless change between the extensive number of kits.

 

The simplicity and ease of use of the QuickGene instruments allows for quick and simple staff training, resulting in top quality extraction every time in a rapid, simple process. It is perfect for PCR testing or other downstream applications in any size lab.

 

Please visit www.alphalabs.co.uk/quickgene  for further information or contact Alpha Laboratories on 0800 38 77 32 or email marketing@alphalabs.co.uk  

Related

Invasive Aspergillosis Screening in COVID-19 & Critical Care Patients

IMMY sõna Aspergillus Galactomannan Lateral Flow Assay recommended by the European Confederation of ...

Read More >

European Reference Laboratory for Glycohemoglobin study reaffirms EKF’s Quo-Test® meets HbA1c performance criteria

Cardiff, UK – 16th February 2017 – EKF Diagnostics, the global in vitro diagnostics company, annou...

Read More >

MBM and OCB launch ColoProg in China on March 7th 2018

Oxford developed prognostic assay for risk of post-surgical recurrence in Stage II colorectal cance...

Read More >

SpeeDx receives CE-IVD mark for multiplex PlexPCR® VHS test for VZV, herpes and syphilis

SYDNEY, AUSTRALIA–(October 25, 2017). SpeeDx Pty. Ltd. has announced that it has received CE-IVD ma...

Read More >

OGT makes market-leading NGS coverage and expertise more accessible

Oxford, UK – 13 June 2019. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expand...

Read More >

SpeeDx receives FDA clearance for Mycoplasma genitalium product

SYDNEY, AUSTRALIA – (April 19, 2018). SpeeDx’s ResistancePlus® MG Positive Control kit has now bee...

Read More >